International Clinical Trial: Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118495) titled 'Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma' on Feb. 6.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The Third Affiliated Hospital of Naval Medical University

Condition: Hepatocellular carcinoma

Intervention: The glucagon-like peptide-1 receptor agonist group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-02-06

Target Sample Size: The glucagon-like peptide-1 receptor agonist group:522;The group of dipeptidyl peptidase-4 inhibitors:523;

Countrie...